-
Study aim
-
Determining the effect of synbiotics on reducing insulin resistance in overweight or obese children
-
Design
-
A clinical trial with parallel groups, double-blinded, randomized (permuted block randomization), phase 3 on 40 children with obesity/overweight, using www.sealedenvelope.com for randomization.
-
Settings and conduct
-
This study is performed in Ali Asghar Children's Hospital. Obese or overweight children are randomly assigned into two groups. In the first group, children receive Synbiotic. In the second group, children receive placebo. In this study, children and physicians did not know the type of medication they received.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Age range between 4 -18 years, Obese or overweight children: Obese children, children with a BMI of more than 95% and overweight children, children with a BMI between 85-95%, Children with insulin resistance (HOMA-IR : > 2.5 = Positive for IR)
Exclusion criteria: Children who developed obesity following syndromic disorder or endocrine disorders, Physical disability, Taking corticosteroids, Treated with metformin, Under special treatment or diet, Acute pancreatitis, History of allergies.
-
Intervention groups
-
In the intervention group, Children receive 1 sachet of probiotic daily (Kidi Lact, manufactured by Zist Takhmir Company, Iran) for 8 weeks. in the Control group: Children received one placebo sachet (manufactured by Zist Takhmir Company, Iran) daily for 8 weeks.
-
Main outcome variables
-
Insulin Resistance level